Pharmacokinetics of magnetic iron oxide nanoparticles for medical applications

J Nowak-Jary, B Machnicka - Journal of Nanobiotechnology, 2022 - Springer
Magnetic iron oxide nanoparticles (MNPs) have been under intense investigation for at least
the last five decades as they show enormous potential for many biomedical applications …

The repertoire of small-molecule PET probes for neuroinflammation imaging: challenges and opportunities beyond TSPO

Z Chen, A Haider, J Chen, Z **ao, L Gobbi… - Journal of medicinal …, 2021 - ACS Publications
Neuroinflammation is an adaptive response of the central nervous system to diverse
potentially injurious stimuli, which is closely associated with neurodegeneration and …

Molecular alterations of the endocannabinoid system in psychiatric disorders

D Navarro, A Gasparyan, F Navarrete… - International journal of …, 2022 - mdpi.com
The therapeutic benefits of the current medications for patients with psychiatric disorders
contrast with a great variety of adverse effects. The endocannabinoid system (ECS) …

Evaluation of [18F]RoSMA-18-d6 as a CB2 PET Radioligand in Nonhuman Primates

A Haider, L Wang, L Gobbi, Y Li… - ACS chemical …, 2023 - ACS Publications
The cannabinoid type 2 receptor (CB2) has been implicated in a variety of central and
peripheral inflammatory diseases, prompting significant interest in the development of CB2 …

Cannabidiol and neurodevelopmental disorders in children

KA Kwan Cheung, MD Mitchell, HS Heussler - Frontiers in Psychiatry, 2021 - frontiersin.org
Neurodevelopmental and neuropsychiatric disorders (such as autism spectrum disorder)
have broad health implications for children, with no definitive cure for the vast majority of …

Translational Preclinical PET Imaging and Metabolic Evaluation of a New Cannabinoid 2 Receptor (CB2R) Radioligand, (Z)-N-(3-(2-(2-[18F]Fluoroethoxy)ethyl)-4,5 …

S Auvity, B Attili, F Caillé, M Goislard… - ACS Pharmacology & …, 2024 - ACS Publications
We have previously developed seven fluorinated analogues of A-836339 as new PET
tracers for cannabinoid type 2 receptor (CB2R) imaging, among which (Z)-N-(3-(2-(2-[18F] …

Strategies for designing novel positron emission tomography (PET) radiotracers to cross the blood–brain barrier

A Lindberg, M Chassé, C Varlow… - Journal of Labelled …, 2023 - Wiley Online Library
Positron emission tomography (PET) is a powerful tool for imaging biological processes in
the central nervous system (CNS). Designing PET radiotracers capable of crossing the …

Non-invasive mass and temperature quantifications with spectral CT

LP Liu, M Hwang, M Hung, MC Soulen, TP Schaer… - Scientific Reports, 2023 - nature.com
Spectral CT has been increasingly implemented clinically for its better characterization and
quantification of materials through its multi-energy results. It also facilitates calculation of …

Structure-Based Design, Optimization, and Development of [18F]LU13: A Novel Radioligand for Cannabinoid Receptor Type 2 Imaging in the Brain with PET

D Gündel, W Deuther-Conrad… - Journal of Medicinal …, 2022 - ACS Publications
The cannabinoid receptor type 2 (CB2R) is an attractive target for the diagnosis and therapy
of neurodegenerative diseases and cancer. In this study, we aimed at the development of a …

Development of high brain-penetrant and reversible monoacylglycerol lipase PET tracers for neuroimaging

Y He, M Schild, U Grether, J Benz… - Journal of medicinal …, 2022 - ACS Publications
Monoacylglycerol lipase (MAGL) is one of the key enzymes in the endocannabinoid system.
Inhibition of MAGL has been proposed as an attractive approach for the treatment of various …